VCELVericel Corp

Nasdaq vcel.com


$ 47.62 $ -1.79 (-3.62 %)    

Thursday, 16-May-2024 15:59:24 EDT
QQQ $ 451.64 $ -0.92 (-0.2 %)
DIA $ 399.14 $ -0.07 (-0.02 %)
SPY $ 528.49 $ -1.29 (-0.24 %)
TLT $ 92.06 $ -0.04 (-0.04 %)
GLD $ 220.06 $ -0.86 (-0.39 %)
$ 47.61
$ 48.86
$ 0.00 x 0
$ 0.00 x 0
$ 47.30 - $ 48.86
$ 30.18 - $ 53.05
445,716
na
2.29B
$ 1.64
$ 5,082.02
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-08-2024 03-31-2024 10-Q
2 02-29-2024 12-31-2023 10-K
3 11-08-2023 09-30-2023 10-Q
4 08-02-2023 06-30-2023 10-Q
5 05-10-2023 03-31-2023 10-Q
6 02-23-2023 12-31-2022 10-K
7 11-09-2022 09-30-2022 10-Q
8 08-03-2022 06-30-2022 10-Q
9 05-04-2022 03-31-2022 10-Q
10 02-24-2022 12-31-2021 10-K
11 11-09-2021 09-30-2021 10-Q
12 08-04-2021 06-30-2021 10-Q
13 05-05-2021 03-31-2021 10-Q
14 02-24-2021 12-31-2020 10-K
15 11-05-2020 09-30-2020 10-Q
16 08-05-2020 06-30-2020 10-Q
17 05-11-2020 03-31-2020 10-Q
18 02-25-2020 12-31-2019 10-K
19 11-05-2019 09-30-2019 10-Q
20 08-06-2019 06-30-2019 10-Q
21 05-07-2019 03-31-2019 10-Q
22 02-26-2019 12-31-2018 10-K
23 11-06-2018 09-30-2018 10-Q
24 08-06-2018 06-30-2018 10-Q
25 05-08-2018 03-31-2018 10-Q
26 03-05-2018 12-31-2017 10-K
27 11-07-2017 09-30-2017 10-Q
28 08-09-2017 06-30-2017 10-Q
29 05-10-2017 03-31-2017 10-Q
30 03-13-2017 12-31-2016 10-K
31 11-07-2016 09-30-2016 10-Q
32 08-08-2016 06-30-2016 10-Q
33 05-10-2016 03-31-2016 10-Q
34 03-14-2016 12-31-2015 10-K
35 11-13-2015 09-30-2015 10-Q
36 08-12-2015 06-30-2015 10-Q
37 05-14-2015 03-31-2015 10-Q
38 03-25-2015 12-31-2014 10-K
39 11-13-2014 09-30-2014 10-Q
40 08-14-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-maintains-buy-on-vericel-raises-price-target-to-55

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Vericel (NASDAQ:VCEL) with a Buy and raises the price targe...

 vericel-raises-fy24-revenue-guidance-from-237m-241m-to-238m-242m-vs-23924m-est

2024 Financial GuidanceTotal net revenue for 2024 now expected to be in the range of $238 to $242 million, compared to the prev...

 vericel-q1-eps-008-beats-011-estimate-sales-5128m-beat-4907m-estimate

Vericel (NASDAQ:VCEL) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.11) by 27...

 truist-securities-reiterates-buy-on-vericel-maintains-54-price-target

Truist Securities analyst Samuel Brodovsky reiterates Vericel (NASDAQ:VCEL) with a Buy and maintains $54 price target.

 truist-securities-maintains-buy-on-vericel-raises-price-target-to-54

Truist Securities analyst Samuel Brodovsky maintains Vericel (NASDAQ:VCEL) with a Buy and raises the price target from $51 t...

 hc-wainwright--co-maintains-buy-on-vericel-raises-price-target-to-53

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Vericel (NASDAQ:VCEL) with a Buy and raises the price targe...

 vericel-q4-gaap-eps-026-beats-017-estimate-sales-6500m-beat-6393m-estimate

Vericel (NASDAQ:VCEL) reported quarterly earnings of $0.26 per share which beat the analyst consensus estimate of $0.17 by 52.9...

 earnings-scheduled-for-february-29-2024

Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on reve...

 truist-securities-upgrades-vericel-to-buy-raises-price-target-to-51

Truist Securities analyst Samuel Brodovsky upgrades Vericel (NASDAQ:VCEL) from Hold to Buy and raises the price target from ...

 hc-wainwright--co-maintains-buy-on-vericel-raises-price-target-to-46

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Vericel (NASDAQ:VCEL) with a Buy and raises the price targe...

 innovative-burn-care-mediwound-bags-additional-dod-grant-for-nexobrid-development

Biopharmaceutical company MediWound Ltd (NASDAQ: MDWD) reported that the U.S.

 truist-securities-maintains-hold-on-vericel-raises-price-target-to-39-report-released-on-8th-nov-2023

Truist Securities analyst Samuel Brodovsky maintains Vericel (NASDAQ:VCEL) with a Hold and raises the price target from $33 ...

 truist-securities-maintains-hold-on-vericel-raises-price-target-to-39

Truist Securities analyst Samuel Brodovsky maintains Vericel (NASDAQ:VCEL) with a Hold and raises the price target from $33 ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION